Viracept (nelfinavir mesylate, AG1343): a potent, orally bioavailable inhibitor of HIV-1 protease.
暂无分享,去创建一个
J F Davies | K Appelt | A K Patick | S W Kaldor | V J Kalish | B V Shetty | J E Fritz | J A Burgess | K M Campanale | N Y Chirgadze | D K Clawson | B A Dressman | S D Hatch | D A Khalil | M B Kosa | P P Lubbehusen | M A Muesing | S H Reich | K S Su | J H Tatlock
[1] M. Boyd,et al. New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity. , 1989, Journal of the National Cancer Institute.
[2] A. Freeman,et al. Studies toward the Large-Scale Synthesis of the HIV Proteinase Inhibitor Ro 31-8959 , 1994 .
[3] K. Appelt,et al. Crystal structures of HIV-1 protease-inhibitor complexes , 1993 .
[4] J. Huff,et al. HIV protease: a novel chemotherapeutic target for AIDS. , 1991, Journal of medicinal chemistry.
[5] P. Darke,et al. HIV protease as an inhibitor target for the treatment of AIDS. , 1994, Advances in pharmacology.
[6] K. Appelt,et al. Protein structure-based design of potent orally bioavailable, nonpeptide inhibitors of human immunodeficiency virus protease. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[7] D. Ho,et al. Antiviral and resistance studies of AG1343, an orally bioavailable inhibitor of human immunodeficiency virus protease , 1996, Antimicrobial agents and chemotherapy.
[8] K. Appelt,et al. Isophthalic acid derivatives: amino acid surrogates for the inhibition of HIV-1 protease , 1995 .
[9] J. Vederas,et al. Conversion of serine to stereochemically pure .beta.-substituted .alpha.-amino acids via .beta.-lactones , 1985 .
[10] I B Duncan,et al. Rational design of peptide-based HIV proteinase inhibitors. , 1990, Science.
[11] P. Darke,et al. L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[12] S. Vasavanonda,et al. ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[13] S. Redshaw,et al. Studies Toward the Large-Scale Synthesis of the HIV Proteinase Inhibitor Ro 31-8959. , 1994 .
[14] K. Appelt,et al. Structure-based design and synthesis of substituted 2-butanols as nonpeptidic inhibitors of HIV protease: secondary amide series. , 1996, Journal of medicinal chemistry.